Truseltiq(Infigratinib) Side Effects

Common adverse reactions include nail toxicity, stomatitis, dry eye, fatigue, alopecia, and palmar-plantar erythrodysesthesia syndrome.

Adverse Reactions

The most frequently reported adverse reactions, occurring in 20% or more of patients, encompass nail disorders, inflammation of the mouth lining (stomatitis), ocular dryness, generalized fatigue, hair loss, and hand-foot skin reaction syndrome. Other common effects involve joint pain, taste distortion, constipation, abdominal discomfort, dry mouth, eyelash changes, diarrhea, skin dryness, reduced appetite, blurred vision, and vomiting. Laboratory abnormalities often include increased creatinine and phosphate levels, decreased phosphate and hemoglobin, and elevated liver enzymes.

Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved